- $4.20bn
- $4.98bn
- $3.31bn
Annual balance sheet for AAR, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | 2026 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 53.5 | 68.4 | 85.8 | 96.5 | 84 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 288 | 328 | 410 | 495 | 535 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,007 | 1,098 | 1,390 | 1,511 | 1,742 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 349 | 368 | 435 | 424 | 558 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,574 | 1,833 | 2,770 | 2,845 | 3,356 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 348 | 352 | 467 | 555 | 613 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 539 | 734 | 1,580 | 1,633 | 1,652 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,035 | 1,099 | 1,190 | 1,212 | 1,704 |
| Total Liabilities & Shareholders' Equity | 1,574 | 1,833 | 2,770 | 2,845 | 3,356 |
| Total Common Shares Outstanding |